Search Results - Pankti Reid
- Showing 1 - 6 results of 6
-
1
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics by Michael Macklin, Sudeep Yadav, Reem Jan, Pankti Reid
Published in Pharmaceuticals (2023-02-01)Get full text
Article -
2
-
3
Real-World Analysis of Patient Characteristics, Adverse Events, and Economic Burden Among Patients with Giant Cell Arteritis Treated with Glucocorticoids by Jeffrey R. Curtis, Denise T. Kruzikas, Ana Romero, Arathi R. Setty, Yi Peng, Jayesh Patel, Pankti Reid, Frank Buttgereit
Published in Rheumatology and Therapy (2025-07-01)Get full text
Article -
4
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 ‘shared epitope’ are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in l... by Vivian P Bykerk, Anne R Bass, Karmela K Chan, Susan Goodman, Nilasha Ghosh, William H Robinson, Amit Lakhanpal, Pankti Reid, Carlos Andres Aude, Jessica Kirschman, Diviya Rajesh
Published in RMD Open (2023-04-01)Get full text
Article -
5
Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analy... by Jennifer Strouse, Karmela Kimi Chan, Rachel Baccile, Gong He, Diana K. N. Louden, Mihai Giurcanu, Arohi Singh, John Rieth, Noha Abdel-Wahab, Noha Abdel-Wahab, Tamiko R. Katsumoto, Namrata Singh, Sherin Rouhani, Pankti Reid
Published in Frontiers in Immunology (2024-12-01)Get full text
Article -
6
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases by Pankti Reid, Sabina Sandigursky, Juhee Song, Maria A. Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S. Weber, Osama E. Rahma, Maria E. Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Published in OncoImmunology (2023-12-01)Get full text
Article
